Safety Study of Tuberculosis Vaccines AERAS-402 and MVA85A This trial will investigate the administration of two new tuberculosis vaccines, called AERAS-402 and MVA85A. The purpose of this trial is to assess what happens when both of these vaccine...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Aerosol BCG Challenge Trial in Healthy UK Adults TB041 is a clinical challenge trial primarily to evaluate the safety of BCG challenge administered by the aerosol inhaled route in healthy, BCG naive UK adults. The trial will also look to...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV This is an open Phase I study of a candidate TB vaccine, MVA85A, in healthy subjects who are infected with HIV. It is designed to study the safety and immunogenicity of the vaccine.

• Pays Senegal
• Organes Aucun
• Spécialités Aucune

A Study to Quantify Bacille Calmette Guerin (BCG) and Characterise the Immune Response After BCG Vaccination This is a human pilot study of 16 healthy BCG-naïve volunteers to quantify BCG from the BCG vaccination site. Volunteers will be vaccinated with BCG. The first 8 will go on to have a punch...

• Pays United Kingdom
• Organes Aucun
• Spécialités Aucune

A phase I study to compare the safety and immunogenicity of candidate tuberculosis (TB) vaccine MVA85A administered by the intramuscular route and the intradermal route Background and study aims MVA85A is a new vaccine being developed against tuberculosis which is designed to act as a boosting immunisation in people who have already received BCG. In clinical trials ...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG This is a phase I study to examine the safety and immunogenicity of MVA85A delivered intradermally into the deltoid region in volunteers who have recieved BCG in the past 20 years.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Phase I Study to Assess the Safety and Immunogenicity of Tuberculosis (TB) Vaccine Candidates FP85A and MVA85A This is a Phase I study whose primary outcome is to assess the safety of a new tuberculosis vaccine, FP85A, when administered individually and sequentially with MVA85A in a prime-boost reg...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG The dose of recombinant MVA used in the TB trials to date is relatively low compared with other trials using recombinant MVAs which have used up to 2.5 x 108pfu (A Hill, personal communica...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both This study is designed to evaluate the safety of MVA85A in asymptomatic volunteers in South Africa who are infected with M.tb, HIV or both. A single vaccination with MVA85A, when administe...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB This study is designed to evaluate the safety of MVA85A in healthy volunteers in the UK who are latently infected with M.tb. A single vaccination with MVA85A, when administeredat a dose of...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune